Stockreport

Curis Provides First Quarter 2024 Business Update [Yahoo! Finance]

Curis, Inc.  (CRIS) 
Last curis, inc. earnings: 11/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.curis.com
PDF biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and fi [Read more]